Antibiotic Resistance in Sputum Isolates of Streptococcus pneumoniae in Chronic Obstructive Pulmonary Disease is Related to Antibiotic Exposure

REFERENCES

• Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008; 359(22):2355–2365.
   PubMed Web of Science ®Google Scholar
• Wilson R. The role of infection in COPD. Chest 1998; 113(4 Suppl):242S–248S.
   Google Scholar
• White AJ, Gompertz S, Stockley RA. Chronic obstructive pulmonary disease 6: The aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax 2003; 58(1):73–80.
   PubMed Web of Science ®Google Scholar
• Murphy TF, Brauer AL, Eschberger K, Lobbins P, Grove L, Cai X, Sethi S. Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177(8):853–860.
   PubMed Web of Science ®Google Scholar
• Fagon JY, Chastre J, Trouillet JL, Domart Y, Dombret MC, Bornet M, Gibert C. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. Am Rev Respir Dis 1990; 142(5):1004–1008.
   PubMed Web of Science ®Google Scholar
• Monso E, Ruiz J, Rosell A, Manterola J, Fiz J, Morera J, Ausina V. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995; 152(4 Pt 1):1316–1320.
   PubMed Web of Science ®Google Scholar
• Murphy TF, Brauer AL, Grant BJ, Sethi S. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med 2005; 172(2):195–199.
   PubMed Web of Science ®Google Scholar
• Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002; 347(7):465–471.
   PubMed Web of Science ®Google Scholar
• Sethi S, Muscarella K, Evans N, Klingman KL, Grant BJ, Murphy TF. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 2000; 118(6):1557–1565.
   PubMed Web of Science ®Google Scholar
• Sethi S, Wrona C, Grant BJ, Murphy TF. Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 169(4):448–453.
   PubMed Web of Science ®Google Scholar
• Soler N, Torres A, Ewig S, Gonzalez J, Celis R, El-Ebiary M, Hernandez C, Rodriguez-Roisin R. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998; 157(5 Pt 1):1498–1505.
   PubMed Web of Science ®Google Scholar
• White AJ, Gompertz S, Bayley DL, Hill SL, O'Brien C, Unsal I, Stockley RA. Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis. Thorax 2003; 58(8):680–685.
   PubMed Web of Science ®Google Scholar
• Zalacain R, Sobradillo V, Amilibia J, Barron J, Achotegui V, Pijoan JI, Llorente JL. Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J 1999; 13(2):343–348.
   PubMed Web of Science ®Google Scholar
• Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002; 57(9):759–764.
   PubMed Web of Science ®Google Scholar
• Jones ME, Karlowsky JA, Blosser-Middleton R, Critchley IA, Karginova E, Thornsberry C, Sahm DF. Longitudinal assessment of antipneumococcal susceptibility in the United States. Antimicrob Agents Chemother 2002; 46(8):2651–2655.
   PubMed Web of Science ®Google Scholar
• Mera RM, Miller LA, Daniels JJ, Weil JG, White AR. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project. Diagn Microbiol Infect Dis 2005; 51(3):195–200.
   PubMed Web of Science ®Google Scholar
• Reinert RR. Resistance phenotypes and multi-drug resistance in Streptococcus pneumoniae (PROTEKT years 1–3 (1999–2002). J Chemother 2004; 16 Suppl 6:35–48.
   PubMedGoogle Scholar
• Bedos JP, Chevret S, Chastang C, Geslin P, Regnier B. Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a French survey. Clin Infect Dis 1996; 22(1):63–72.
   PubMed Web of Science ®Google Scholar
• Clavo-Sanchez AJ, Giron-Gonzalez JA, Lopez-Prieto D, Canueto-Quintero J, Sanchez-Porto A, Vergara-Campos A, Marin-Casanova P, Cordoba-Dona JA. Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study. Clin Infect Dis 1997; 24(6):1052–1059.
   PubMed Web of Science ®Google Scholar
• Nava JM, Bella F, Garau J, Lite J, Morera MA, Marti C, Fontanals D, Font B, Pineda V, Uriz S Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994; 19(5):884–890.
   PubMed Web of Science ®Google Scholar
• Pallares R, Gudiol F, Linares J, Ariza J, Rufi G, Murgui L, Dorca J, Viladrich PF. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med 1987; 317(1):18–22.
   PubMed Web of Science ®Google Scholar
• Vanderkooi OG, Low DE, Green K, Powis JE, McGeer A. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 2005; 40(9):1288–1297.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152(5 Pt 2):S77–121.
   PubMed Web of Science ®Google Scholar
• Ertugrul N, Rodriguez-Barradas MC, Musher DM, Ryan MA, Agin CS, Murphy SJ, Shayegani M, Watson DA. BOX-polymerase chain reaction-based DNA analysis of nonserotypeable Streptococcus pneumoniae implicated in outbreaks of conjunctivitis. J Infect Dis 1997; 176(5):1401–1405.
   PubMed Web of Science ®Google Scholar
• Denys GA, Carey RB. Identification of Streptococcus pneumoniae with a DNA probe. J Clin Microbiol 1992; 30(10):2725–2727.
   PubMed Web of Science ®Google Scholar
• Mundy LS, Janoff EN, Schwebke KE, Shanholtzer CJ, Willard KE. Ambiguity in the identification of Streptococcus pneumoniae. Optochin, bile solubility, quellung, and the AccuProbe DNA probe tests. Am J Clin Pathol 1998; 109(1):55–61.
   PubMed Web of Science ®Google Scholar
• Whatmore AM, Efstratiou A, Pickerill AP, Broughton K, Woodard G, Sturgeon D, George R, Dowson CG. Genetic relationships between clinical isolates of Streptococcus pneumoniae, Streptococcus oralis, and Streptococcus mitis: characterization of “Atypical” pneumococci and organisms allied to S. mitis harboring S. pneumoniae virulence factor-encoding genes. Infect Immun 2000; 68(3):1374–1382.
   PubMed Web of Science ®Google Scholar
• McEllistrem MC, Stout JE, Harrison LH. Simplified protocol for pulsed-field gel electrophoresis analysis of Streptococcus pneumoniae. J Clin Microbiol 2000; 38(1):351–353.
   PubMed Web of Science ®Google Scholar
• Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33(9):2233–2239.
   PubMed Web of Science ®Google Scholar
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. In., 6th edn. Clinical and Laboratory Standards Institute; Wayne, PA, USA: 2003
   Google Scholar
• Performance standards for antimicrobial susceptibility testing: 15th informational supplement. In Clinical and Laboratory Standards Institute; Wayne, PA, USA: 2005; M100–S115.
   Google Scholar
• Performance standards for antimicrobial susceptibility testing: 18th informational supplement. In Clinical and Laboratory Standards Institute; Wayne, PA, USA: 2008; M100–S118.
   Google Scholar
• MMWR. Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae—United States, 2006–2007. MMWR Morb Mortal Wkly Rep 2008; 57(50):1353–1355.
   PubMedGoogle Scholar
• Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3(2):171–196.
   PubMed Web of Science ®Google Scholar
• Hofmann J, Cetron MS, Farley MM, Baughman WS, Facklam RR, Elliott JA, Deaver KA, Breiman RF. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995; 333(8):481–486.
   PubMed Web of Science ®Google Scholar
• Butler JC, Hofmann J, Cetron MS, Elliott JA, Facklam RR, Breiman RF. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis 1996; 174(5):986–993.
   PubMed Web of Science ®Google Scholar
• Moreno S, Garcia-Leoni ME, Cercenado E, Diaz MD, Bernaldo de Quiros JC, Bouza E. Infections caused by erythromycin-resistant Streptococcus pneumoniae: incidence, risk factors, and response to therapy in a prospective study. Clin Infect Dis 1995; 20(5):1195–1200.
   PubMed Web of Science ®Google Scholar
• Reinert RR, Al-Lahham A, Lemperle M, Tenholte C, Briefs C, Haupts S, Gerards HH, Lutticken R. Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany. J Antimicrob Chemother 2002; 49(1):61–68.
   PubMed Web of Science ®Google Scholar
• Seppala H, Nissinen A, Jarvinen H, Huovinen S, Henriksson T, Herva E, Holm SE, Jahkola M, Katila ML, Klaukka T Resistance to erythromycin in group A streptococci. N Engl J Med 1992; 326(5):292–297.
   PubMed Web of Science ®Google Scholar
• Kelley MA, Weber DJ, Gilligan P, Cohen MS. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. Clin Infect Dis 2000; 31(4):1008–1011.
   PubMed Web of Science ®Google Scholar
• Daneman N, McGeer A, Green K, Low DE. Macrolide resistance in bacteremic pneumococcal disease: implications for patient management. Clin Infect Dis 2006; 43(4):432–438.
   PubMed Web of Science ®Google Scholar
• Robins-Browne RM, Kharsany AB, Koornhof HJ. Antibiotic-resistant pneumococci in hospitalized children. J Hyg (Lond) 1984; 93(1):9–16.
   PubMedGoogle Scholar
• Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, Lode H. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest 1998; 113(6):1542–1548.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Espinosa C, Fernandez-Laso E, Martos JA, Maldonado JA, Gallego M. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD Study Group of Bacterial Infection in COPD. Chest 1999; 116(1):40–46.
   PubMed Web of Science ®Google Scholar